{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:54:31Z","timestamp":1785894871317,"version":"3.56.0"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ejmech.2021.113408","type":"journal-article","created":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T09:34:13Z","timestamp":1617528853000},"page":"113408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Advancement of chimeric hybrid drugs to cure malaria infection: An overview with special emphasis on endoperoxide pharmacophores"],"prefix":"10.1016","volume":"219","author":[{"given":"Bhawana","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6497-7257","authenticated-orcid":false,"given":"Ashawani Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1105-1431","authenticated-orcid":false,"given":"Satish K.","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejmech.2021.113408_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/microorganisms7060179","article-title":"Malaria: the past and the present","volume":"7","author":"Talapk","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejmech.2021.113408_bib2","doi-asserted-by":"crossref","first-page":"111353","DOI":"10.1016\/j.ejmech.2019.05.043","article-title":"New dimensions in the field of antimalarial research against malaria resurgence","volume":"181","author":"Narula","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/1475-2875-10-378","article-title":"A\u00a0new world malaria map: Plasmodium falciparum endemicity in 2010","volume":"10","author":"Gething","year":"2011","journal-title":"Malar. J."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113408_bib4a","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1086\/524888","article-title":"Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening","volume":"46","author":"Cox-Singh","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113408_bib4b","first-page":"299","article-title":"The emerging of the fifth malaria parasite (Plasmodium knowlesi) A public health concern?","volume":"14","author":"Sabbatani","year":"2010","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113408_bib5a","first-page":"492","article-title":"Plasmodium vivax msp-3a polymorphisms: analysis in the Indian subcontinent, Malar","volume":"15","author":"Verma","year":"2016","journal-title":"J"},{"key":"10.1016\/j.ejmech.2021.113408_bib5b","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pt.2008.01.007","article-title":"Plasmodium vivax in India","volume":"24","author":"Joshi","year":"2008","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2021.113408_bib5c","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4269\/ajtmh.2001.64.97","article-title":"The neglected burden of Plasmodium vivax malaria","volume":"64","author":"Mendis","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2021.113408_bib5d","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/1475-2875-12-243","article-title":"Molecular epidemiology of Plasmodium vivax in Latin America: polymorphism and evolutionary relationships of the circumsporozoite gene","volume":"12","author":"Gonzalez-Ceron","year":"2013","journal-title":"Malar. J."},{"issue":"9754","key":"10.1016\/j.ejmech.2021.113408_bib5e","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0140-6736(10)60831-8","article-title":"Adult and child malaria mortality in India: a nationally representative mortality survey","volume":"376","author":"Dhingra","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113408_bib6","series-title":"Malaria Report 2003","year":"2003"},{"key":"10.1016\/j.ejmech.2021.113408_bib7","series-title":"World Malaria Report","year":"2019"},{"issue":"9608","key":"10.1016\/j.ejmech.2021.113408_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0140-6736(07)61690-0","article-title":"Maternal and child undernutrition: global and regional exposures and health consequences","volume":"371","author":"Black","year":"2008","journal-title":"The lancet"},{"issue":"11","key":"10.1016\/j.ejmech.2021.113408_bib9","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/jnnp.57.11.1333","article-title":"Pierre joseph pelletier (1788-1842) and jean bienaime Caventou (1795-1887)","volume":"57","author":"Haas","year":"1994","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.ejmech.2021.113408_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1021\/cb8002804","article-title":"Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria","volume":"4","author":"Dasgupta","year":"2009","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113408_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-012-2886-x","article-title":"From methylene blue to chloroquine: a brief review of the development of an antimalarial therapy","volume":"111","author":"Krafts","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejmech.2021.113408_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1473-3099(09)70177-X","article-title":"Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite","volume":"9","author":"Mueller","year":"2009","journal-title":"Lancet Infect. Dis."},{"issue":"11","key":"10.1016\/j.ejmech.2021.113408_bib13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrd1230","article-title":"Science & society: virtual drug discovery and development for neglected diseases through public\u2013private partnerships","volume":"2","author":"Nwaka","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113408_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006930","article-title":"Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites","volume":"14","author":"Rocamora","year":"2018","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.ejmech.2021.113408_bib15","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1016\/j.ejmech.2009.02.024","article-title":"Recent developments in the design and synthesis of hybrid molecules basedon aminoquinoline ring and their antiplasmodial evaluation","volume":"44","author":"Kouznetsov","year":"2009","journal-title":"Eur. J. Med. Chem."},{"issue":"4216","key":"10.1016\/j.ejmech.2021.113408_bib16","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.1105787","article-title":"Mefloquine (WR 142,490) in the treatment of human malaria","volume":"190","author":"Trenholme","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113408_bib17","article-title":"Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign","volume":"11","author":"Talundzic","year":"2015","journal-title":"PLoS Pathog."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113408_bib18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2011.08.024","article-title":"Artemisinin: discovery from the Chinese herbal garden","volume":"146","author":"Miller","year":"2011","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113408_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1039\/c2md00277a","article-title":"Antimalarial peroxides: advances in drug discovery and design","volume":"3","author":"Slack","year":"2012","journal-title":"Med. Chem. Comm."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113408_bib20a","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2174\/092986711794927748","article-title":"Road towards new antimalarials-overview of the strategies and their chemical progress","volume":"18","author":"Wu","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"25","key":"10.1016\/j.ejmech.2021.113408_bib20b","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.2174\/092986711803414340","article-title":"Medicinal chemistry perspectives of trioxanes and tetraoxanes","volume":"18","author":"Kumar","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/expr.1993.1010","article-title":"Plasmodium falciparum: in\u00a0vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria","volume":"76","author":"Terkuile","year":"1993","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113408_bib22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF00930817","article-title":"Stage-specific gametocytocidal effect in\u00a0vitro of the antimalaria drug qinghaosu on Plasmodium falciparum","volume":"76","author":"Kumar","year":"1990","journal-title":"Parasitol. Res."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113408_bib23a","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4269\/ajtmh.2001.65.690","article-title":"Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy?","volume":"65","author":"Giao","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"9430","key":"10.1016\/j.ejmech.2021.113408_bib23b","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(04)16680-4","article-title":"Antimalarial combinations","volume":"364","author":"Kremsner","year":"2004","journal-title":"Lancet"},{"issue":"4703","key":"10.1016\/j.ejmech.2021.113408_bib24","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): an antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ejmech.2021.113408_bib25","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1021\/ar100070k","article-title":"Heme as trigger and target for trioxane-containing antimalarial drugs","volume":"43","author":"Meunier","year":"2010","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113408_bib26","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1016\/j.bmcl.2010.10.116","article-title":"Synthesis and in\u00a0vitro evaluation of novel coumarin-chalcone hybrids as potential anticancer agents","volume":"20","author":"Sashidhara","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"16","key":"10.1016\/j.ejmech.2021.113408_bib27","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1021\/jm00094a015","article-title":"Dispiro-1, 2, 4, 5-tetraoxanes: a new class of antimalarial peroxides","volume":"35","author":"Vennerstrom","year":"1992","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113408_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0014-5793(94)00921-X","article-title":"Quinoline anti-malarial drugs inhibit spontaneous formation of \u03b2-haematin (malaria pigment)","volume":"352","author":"Egan","year":"1994","journal-title":"FEBS Lett."},{"issue":"177","key":"10.1016\/j.ejmech.2021.113408_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005029","article-title":"Quinolone-3-diarylethers: a new class of antimalarial drug","volume":"5","author":"Nilsen","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113408_bib30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0035-9203(97)90032-8","article-title":"Artesunate\/mefloquine treatment of multi-drug resistant falciparum malaria","volume":"91","author":"Price","year":"1997","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"45","key":"10.1016\/j.ejmech.2021.113408_bib31","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1016\/j.tetlet.2012.08.134","article-title":"Unique trifurcated hydrogen bonding in a pseudopolymorph of tricyclohexane triperoxide (TCTP) and its thermal studies","volume":"53","author":"Neupane","year":"2012","journal-title":"Tetrahedron Lett."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113408_bib32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/molecules22020323","article-title":"Design of drug delivery systems containing artemisinin and its derivatives","volume":"22","author":"Aderibigbe","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113408_bib33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/00498254.2015.1070975","article-title":"Characterisation of artemisinin-chloroquinoline hybrids for potential metabolic liabilities","volume":"46","author":"Thelingwani","year":"2016","journal-title":"Xenobiotica"},{"issue":"13","key":"10.1016\/j.ejmech.2021.113408_bib34","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1016\/j.bmcl.2007.04.054","article-title":"A\u00a0novel artemisinin\u2013quinine hybrid with potent antimalarial activity","volume":"17","author":"Walsh","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"25","key":"10.1016\/j.ejmech.2021.113408_bib35","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.2174\/138161209789058183","article-title":"Hybrid drugs for malaria","volume":"15","author":"Walsh","year":"2009","journal-title":"Curr. Pharmaceut. Des."},{"issue":"11","key":"10.1016\/j.ejmech.2021.113408_bib36","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1039\/c3ra42513d","article-title":"Diversification in the synthesis of antimalarial trioxane and tetraoxane analogs","volume":"4","author":"Yadav","year":"2014","journal-title":"RSC Adv."},{"issue":"11","key":"10.1016\/j.ejmech.2021.113408_bib37","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1021\/jm00394a037","article-title":"Antimalarial activity of new water-soluble dihydroartemisinin derivatives","volume":"30","author":"Lin","year":"1987","journal-title":"J.\u00a0Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113408_bib38","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/molecules15031705","article-title":"The molecular mechanism of action of artemisinin\u2014the debate continues","volume":"15","author":"O\u2019neill","year":"2010","journal-title":"Molecules"},{"issue":"16","key":"10.1016\/j.ejmech.2021.113408_bib39","doi-asserted-by":"crossref","first-page":"7853","DOI":"10.1016\/j.bmc.2008.02.034","article-title":"Heme activates artemisinin more efficiently than hemin, inorganic iron, or hemoglobin","volume":"16","author":"Zhang","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113408_bib40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1471-4922(00)01838-9","article-title":"Possible modes of action of the artemisinin-type compounds","volume":"17","author":"Olliaro","year":"2001","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2021.113408_bib41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1021\/ar020227u","article-title":"Knowledge of the proposed chemical mechanism of action and cytochrome p450 metabolism of antimalarial trioxanes like artemisinin allows rational design of new antimalarial peroxides","volume":"37","author":"Posner","year":"2004","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113408_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The past, present and future of anti-malarial medicines","volume":"18","author":"Tse","year":"2019","journal-title":"Malar. J."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113408_bib43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/jm980529v","article-title":"Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family","volume":"42","author":"Posner","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2021.113408_bib44a","first-page":"1200","article-title":"The rat biliary metabolites of dihydroartemisinin, an antimalarial endoperoxide","volume":"25","author":"Maggs","year":"1997","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113408_bib44b","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0090-9556(24)15130-6","article-title":"Biliary metabolites of \u03b2-artemether in rats: biotransformations of an antimalarial endoperoxide","volume":"28","author":"Maggs","year":"2000","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113408_bib44c","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/138920009787846323","article-title":"Pharmacokinetics and pharmacodynamics of endoperoxide antimalarials","volume":"10","author":"Gautam","year":"2009","journal-title":"Curr. Drug Metabol."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113408_bib44d","first-page":"421","article-title":"Plasmodium falciparum: in\u00a0vitro interaction of quassin and neo-quassin with artesunate, a hemisuccinate derivative of artemisinin, Experiment","volume":"124","author":"Mishra","year":"2010","journal-title":"Parasitology"},{"issue":"2","key":"10.1016\/j.ejmech.2021.113408_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.toxlet.2003.12.009","article-title":"Artemisinin derivatives: toxic for laboratory animals, safe for humans?","volume":"147","author":"Gordi","year":"2004","journal-title":"Toxicol. Lett."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113408_bib46","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2125.2001.01458.x","article-title":"A\u00a0comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malaria","volume":"52","author":"Suputtamongkol","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5874","key":"10.1016\/j.ejmech.2021.113408_bib47","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.1155165","article-title":"Qinghaosu (artemisinin): the price of success","volume":"320","author":"White","year":"2008","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ejmech.2021.113408_bib48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1475-2875-10-281","article-title":"Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya","volume":"10","author":"Lawford","year":"2011","journal-title":"Malar. J."},{"issue":"181","key":"10.1016\/j.ejmech.2021.113408_bib49","article-title":"Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in binh phuoc province, vietnam: 1998-2009","volume":"9","author":"Thanh","year":"2010","journal-title":"Malar. J."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113408_bib50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00003088-199937020-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine","volume":"37","author":"White","year":"1999","journal-title":"Clin. Pharmacokinet."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113408_bib51","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1021\/jm030571c","article-title":"A\u00a0medicinal chemistry perspective on artemisinin and related endoperoxides","volume":"47","author":"O\u2019Neill","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"issue":"9315","key":"10.1016\/j.ejmech.2021.113408_bib52","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(02)08348-4","article-title":"Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial","volume":"359","author":"Adjuik","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejmech.2021.113408_bib53","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/jm0109816","article-title":"Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of new diamine containing analogues","volume":"45","author":"Hindley","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113408_bib54a","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.4269\/ajtmh.2007.77.1005","article-title":"Assessment of the relative advantage of various artesunate-based combination therapies by a multi-treatment Bayesian random-effects meta-analysis","volume":"77","author":"Jansen","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113408_bib54b","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","article-title":"Artemisinin-based combination treatment of falciparum malaria","volume":"77","author":"Nosten","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113408_bib54c","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.qco.0000186848.46417.6c","article-title":"Artemisinin-based combinations","volume":"18","author":"Ashley","year":"2005","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113408_bib54d","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"Van Griensven","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113408_bib55","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1038\/ncomms11553","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","volume":"7","author":"Veiga","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113408_bib56a","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0140-6736(20)30560-2","article-title":"Are three drugs for malaria better than two?","volume":"395","author":"Rosenthal","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113408_bib56b","series-title":"Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial, Lancet 395","first-page":"1345","author":"van der Pluijm","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113408_bib56c","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12936-019-2955-z","article-title":"Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance","volume":"18","author":"White","year":"2019","journal-title":"Malar. J."},{"issue":"51","key":"10.1016\/j.ejmech.2021.113408_bib57","doi-asserted-by":"crossref","first-page":"9129","DOI":"10.1016\/S0040-4039(99)01891-2","article-title":"Application of the TMSOTf AgClO4 activator system to the synthesis of novel, potent, C-10 phenoxy derivatives of dihydroartemisinin","volume":"40","author":"O\u2019Neill","year":"1999","journal-title":"Tetrahedron Lett."},{"issue":"20","key":"10.1016\/j.ejmech.2021.113408_bib58","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1021\/jm00020a028","article-title":"Synthesis and antimalarial activities of several fluorinated artemisinin derivatives","volume":"38","author":"Pu","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2021.113408_bib59a","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1021\/ol052056+","article-title":"Synthesis of new artemisinin-derived dimers by self-cross-metathesis reaction","volume":"7","author":"Grellepois","year":"2005","journal-title":"Org. Lett."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113408_bib59b","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/cmdc.200600156","article-title":"Fluoroartemisinins: metabolically more stable antimalarial artemisinin derivatives","volume":"2","author":"B\u00e9gu\u00e9","year":"2007","journal-title":"ChemMedChem: Chemistry Enabling Drug Discovery"},{"issue":"10","key":"10.1016\/j.ejmech.2021.113408_bib60","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1021\/jm0310333","article-title":"Fluoroartemisinin: trifluoromethyl analogues of artemether and artesunate","volume":"47","author":"Magueur","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib61","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1021\/jm00171a041","article-title":"Antimalarial activity of new water-soluble dihydroartemisinin derivatives. 3.1,2 aromatic amine analogues","volume":"33","author":"Lin","year":"1990","journal-title":"J.\u00a0Med. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2021.113408_bib62","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/anie.200503071","article-title":"Artemisone-a highly active antimalarial drug of the artemisinin class","volume":"45","author":"Haynes","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113408_bib63","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1475-2875-9-227","article-title":"Artemisone effective against murine cerebral malaria","volume":"9","author":"Waknine-Grinberg","year":"2010","journal-title":"Malar. J."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113408_bib64","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4269\/ajtmh.2006.75.637","article-title":"In\u00a0vitro activity of artemisone compared with artesunate against Plasmodium falciparum","volume":"75","author":"Ramharter","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2021.113408_bib65","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/jm00004a007","article-title":"Synthesis and antimalarial activities of 12\u03b2-allyldeoxoartemisinin and its derivatives","volume":"38","author":"Pu","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib66","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1021\/jm020244p","article-title":"Synthesis, stability, and antimalarial activity of new hydrolytically stable and water-soluble (+)-Deoxoartelinic acid","volume":"45","author":"Jung","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113408_bib67","article-title":"Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers","volume":"5","author":"Boger","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2021.113408_bib68","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/jm980529v","article-title":"Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family","volume":"42","author":"Posner","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib69a","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/jm901216v","article-title":"Modular synthesis and in\u00a0vitro and in\u00a0vivo antimalarial assessment of C-10 pyrrole mannich base derivatives of artemisinin","volume":"53","author":"Pacorel","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib69b","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/jm0109816","article-title":"Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of new diamine containing analogues","volume":"45","author":"Hindley","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113408_bib70","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1021\/ar020227u","article-title":"Knowledge of the proposed chemical mechanism of action and cytochrome P450 metabolism of antimalarial trioxanes like artemisinin allows rational design of new antimalarial peroxides","volume":"37","author":"Posner","year":"2004","journal-title":"Acc. Chem. Res."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113408_bib71a","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/jm9911027","article-title":"Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism: comparison between mono-and bisquaternary ammonium salts","volume":"43","author":"Calas","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113408_bib71b","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1021\/jm020461q","article-title":"Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy","volume":"46","author":"Posner","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2021.113408_bib71c","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1021\/jm058288w","article-title":"Second generation, orally active, antimalarial, artemisinin-derived trioxane dimers with high stability, efficacy, and anticancer activity","volume":"49","author":"Paik","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib71d","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1517\/13543776.16.12.1665","article-title":"Anticancer activity of artemisinin-derived trioxanes","volume":"16","author":"Posner","year":"2006","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113408_bib71e","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00304940609355981","article-title":"Recent progress in the synthesis of artemisinin and its derivatives","volume":"38","author":"Kim","year":"2006","journal-title":"Org. Prep. Proced. Int."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113408_bib71f","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1021\/jm801484v","article-title":"Malaria-infected mice are cured by a single oral dose of new dimeric trioxane sulfones which are also selectively and powerfully cytotoxic to cancer cells","volume":"52","author":"Rosenthal","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2021.113408_bib71g","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1021\/jm9005934","article-title":"Malaria-infected mice live until at least day 30 after a new monomeric trioxane combined with mefloquine are administered together in a single low oral dose","volume":"52","author":"Woodard","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib71h","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/247597","article-title":"Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug","volume":"2012","author":"Crespo-Ortiz","year":"2012","journal-title":"J.\u00a0Biomed. Biotechnol."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113408_bib71i","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1021\/jm400058j","article-title":"Synthesis and antimalarial efficacy of two-carbon-linked, artemisinin-derived trioxane dimers in combination with known antimalarial drugs","volume":"56","author":"Mott","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113408_bib71j","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","article-title":"Development of artemisinin compounds for cancer treatment","volume":"31","author":"Lai","year":"2013","journal-title":"Invest. N. Drugs"},{"issue":"9","key":"10.1016\/j.ejmech.2021.113408_bib72","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.chembiol.2003.09.002","article-title":"The process of structure-based drug design","volume":"10","author":"Anderson","year":"2003","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113408_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/mdh.2013.69","article-title":"Malaria and quinine resistance: a medical and scientific issue between Brazil and Germany (1907\u201319)","volume":"58","author":"Da Silva","year":"2014","journal-title":"Med. Hist."},{"issue":"9699","key":"10.1016\/j.ejmech.2021.113408_bib74","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0140-6736(09)61857-2","article-title":"Artemisinin resistance on the Thai\u2013Cambodian border","volume":"374","author":"M\u00fcller","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejmech.2021.113408_bib75a","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid molecules with a dual mode of action: dream or reality?","volume":"41","author":"Meunier","year":"2007","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113408_bib75b","first-page":"458319","article-title":"Design and synthesis of novel hybrid molecules against malaria","volume":"2015","author":"L\u00f6dige","year":"2015","journal-title":"Int. J. Med. Chem."},{"issue":"71","key":"10.1016\/j.ejmech.2021.113408_bib76","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ddr.20345","article-title":"Next-generation antimalarial drugs: hybrid molecules as a new strategy in drug design","volume":"71","author":"Muregi","year":"2010","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2021.113408_bib77a","doi-asserted-by":"crossref","first-page":"113193","DOI":"10.1016\/j.ejmech.2021.113193","article-title":"Exploration of artemisinin derivatives and synthetic peroxides in antimalarial drug discovery research","volume":"213","author":"Patel","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib77b","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2017.07.061","article-title":"Quinoline hybrids and their antiplasmodial and antimalarial activities","volume":"139","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113408_bib78a","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/1439-7633(20001117)1:4<281::AID-CBIC281>3.0.CO;2-W","article-title":"Preparation and antimalarial activities of \u201ctrioxaquines\u201d, new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline","volume":"1","author":"Dechy-Cabaret","year":"2000","journal-title":"Chembiochem"},{"issue":"45","key":"10.1016\/j.ejmech.2021.113408_bib78b","doi-asserted-by":"crossref","first-page":"17579","DOI":"10.1073\/pnas.0804338105","article-title":"Selection of a trioxaquine as an antimalarial drug candidate","volume":"105","author":"Cosl\u00e9dan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"19","key":"10.1016\/j.ejmech.2021.113408_bib79","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1021\/jm8006905","article-title":"New chimeric antimalarials with 4-aminoquinoline moiety linked to a tetraoxane skeleton","volume":"51","author":"Opsenica","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2021.113408_bib80","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.bmcl.2009.02.013","article-title":"Semi-synthetic and synthetic 1, 2, 4-trioxaquines and 1, 2, 4-trioxolaquines: synthesis, preliminary SAR and comparison with acridine endoperoxide conjugates","volume":"19","author":"Ara\u00fajo","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113408_bib81a","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1021\/ja970412g","article-title":"Characterization of the first covalent adduct between artemisinin and a heme model","volume":"119","author":"Robert","year":"1997","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113408_bib81b","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/(SICI)1521-3765(19980710)4:7<1287::AID-CHEM1287>3.0.CO;2-J","article-title":"Alkylating properties of antimalarial artemisinin derivatives and synthetic trioxanes when activated by a reduced heme model","volume":"4","author":"Robert","year":"1998","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2021.113408_bib81c","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1021\/jo990744z","article-title":"Characterization of the main radical and products resulting from a reductive activation of the antimalarial arteflene (ro 42\u2212 1611)","volume":"64","author":"Cazelles","year":"1999","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib82a","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1128\/mr.60.2.301-315.1996","article-title":"Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy","volume":"60","author":"Meshnick","year":"1996","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2021.113408_bib82b","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1021\/jm970711g","article-title":"Design, synthesis, derivatization, and structure\u2212 activity relationships of simplified, tricyclic, 1, 2, 4-trioxane alcohol analogues of the antimalarial artemisinin","volume":"41","author":"Cummings","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib82c","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1381612805666230109205346","article-title":"Current progress in the chemistry, medicinal chemistry and drug design of artemisinin based antimalarials","volume":"5","author":"Vroman","year":"1999","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2021.113408_bib83","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0010-8545(99)00112-5","article-title":"The role of haem in the activity of chloroquine and related antimalarial drugs","volume":"190","author":"Egan","year":"1999","journal-title":"Coord. Chem. Rev."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113408_bib84","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bcp.2011.04.018","article-title":"Effects of highly active novel artemisinin\u2013chloroquinoline hybrid compounds on \u03b2-hematin formation, parasite morphology and endocytosis in Plasmodium falciparum","volume":"82","author":"Feng","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"17","key":"10.1016\/j.ejmech.2021.113408_bib85","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1016\/j.bmc.2012.06.038","article-title":"Synthesis and evaluation of hybrid drugs for a potential HIV\/AIDS-malaria combination therapy","volume":"20","author":"Aminake","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2021.113408_bib86","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1124\/dmd.30.9.1005","article-title":"Glucuronidation of dihydroartemisinin in\u00a0vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases","volume":"30","author":"Ilett","year":"2002","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113408_bib87","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2125.1992.tb04024.x","article-title":"Extrahepatic metabolism of zidovudine","volume":"33","author":"Howe","year":"1992","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"37","key":"10.1016\/j.ejmech.2021.113408_bib88","doi-asserted-by":"crossref","first-page":"13066","DOI":"10.1002\/anie.201907224","article-title":"Angew. Artemisinin\u2013(Iso) quinoline hybrids by C\u2212 H activation and click chemistry: combating multidrug-resistant malaria","volume":"58","author":"Capci","year":"2019","journal-title":"Chem., Int. Ed."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113408_bib89","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1021\/acsomega.7b00310","article-title":"Synthesis of novel hybrids of quinazoline and artemisinin with high activities against Plasmodium falciparum, human cytomegalovirus, and leukemia cells","volume":"2","author":"Frohlich","year":"2017","journal-title":"ACS Omega"},{"issue":"11","key":"10.1016\/j.ejmech.2021.113408_bib90","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/acsmedchemlett.8b00381","article-title":"Synthesis of artemisinin\u2013estrogen hybrids highly active against HCMV, P. Falciparum, and cervical and breast cancer","volume":"9","author":"Frohlich","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113408_bib91","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1016\/j.bmcl.2018.08.037","article-title":"Synthesis, antimalarial activities and cytotoxicities of amino-artemisinin-1,2-disubstituted ferrocene hybrids","volume":"28","author":"Lange","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"5","key":"10.1016\/j.ejmech.2021.113408_bib92","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/acsmedchemlett.9b00669","article-title":"Synthesis of novel G factor or chloroquine-artemisinin hybrids and conjugates with potent antiplasmodial activity","volume":"11","author":"Pepe","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113408_bib93a","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.285.5433.1573","article-title":"Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs","volume":"285","author":"Jomaa","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113408_bib93b","doi-asserted-by":"crossref","first-page":"24","DOI":"10.7164\/antibiotics.33.24","article-title":"Studies on new phosphonic acid antibiotics. III. Isolation and characterization of FR-31564, FR-32863 and FR-33289","volume":"33","author":"Okuhara","year":"1980","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2021.113408_bib93c","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7164\/antibiotics.33.29","article-title":"Studies on new phosphonic acid antibiotics. IV. Structure determination of FR-33289, FR-31564 and FR-32863","volume":"33","author":"Kuroda","year":"1980","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"issue":"20","key":"10.1016\/j.ejmech.2021.113408_bib94","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.3390\/molecules25204858","article-title":"Synthesis and antiplasmodial activity of novel fosmidomycin derivatives and conjugates with artemisinin and aminochloroquinoline","volume":"25","author":"Palla","year":"2020","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.ejmech.2021.113408_bib95","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1128\/AAC.00510-08","article-title":"Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate, Antimicrob","volume":"52","author":"Varotti","year":"2008","journal-title":"Agents Chemother"},{"issue":"5","key":"10.1016\/j.ejmech.2021.113408_bib96","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1128\/AAC.02216-15","article-title":"Transmission-blocking potential of MEFAS, a hybrid compound derived from artesunate and mefloquine","volume":"60","author":"Penna-Coutinho","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113408_bib97","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1128\/AAC.00967-06","article-title":"Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes","volume":"51","author":"Benoit-Vical","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.ejmech.2021.113408_bib98","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1128\/AAC.00165-08","article-title":"The antimalarial trioxaquine DU1301 alkylates heme in malaria-infected mice","volume":"52","author":"Garah","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.ejmech.2021.113408_bib99","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1371\/journal.pbio.0030255","article-title":"After 30 years of study, the bacterial SOS response still surprises us","volume":"3","author":"Michel","year":"2005","journal-title":"PLoS Biol."},{"issue":"7","key":"10.1016\/j.ejmech.2021.113408_bib100","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/chem.200305576","article-title":"Synthesis and antimalarial activity of trioxaquine derivatives","volume":"10","author":"Dechy-Cabaret","year":"2004","journal-title":"Chemistry\u2013A European Journal"},{"issue":"1","key":"10.1016\/j.ejmech.2021.113408_bib101","article-title":"Synthesis and biological evaluation of a new trioxaquine containing a trioxane moiety obtained by halogenocyclisation of a hemiperoxyacetal","volume":"6","author":"Dechy-Cabaret","year":"2003","journal-title":"Compt. Rendus Chem."},{"issue":"25","key":"10.1016\/j.ejmech.2021.113408_bib102a","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1021\/ja970412g","article-title":"Characterization of the first covalent adduct between artemisinin and a heme model","volume":"119","author":"Robert","year":"1997","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113408_bib102b","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1039\/b110817b","article-title":"Alkylation of heme by the antimalarial drug artemisinin","volume":"5","author":"Robert","year":"2002","journal-title":"Chem. Commun."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113408_bib102c","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1021\/ar990164o","article-title":"From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs","volume":"35","author":"Robert","year":"2002","journal-title":"Acc. Chem. Res."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113408_bib102d","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1128\/AAC.45.6.1886-1888.2001","article-title":"In\u00a0vitro activities of DU-1102, a new trioxaquine derivative, against Plasmodium falciparum isolates, Antimicrob","volume":"45","author":"Basco","year":"2001","journal-title":"Agents Chemother"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113408_bib103a","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1021\/jo010688d","article-title":"Alkylating capacity and reaction products of antimalarial trioxanes after activation by a heme model","volume":"67","author":"Cazelles","year":"2002","journal-title":"J.\u00a0Org. Chem."},{"issue":"4254","key":"10.1016\/j.ejmech.2021.113408_bib103b","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ejmech.2021.113408_bib104","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.bmc.2003.11.021","article-title":"Synthesis and antimalarial activity of a new series of trioxaquines","volume":"12","author":"Singh","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib105","first-page":"849","volume":"13\/457","author":"Fraisse","year":"2012"},{"issue":"10","key":"10.1016\/j.ejmech.2021.113408_bib106","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1021\/jm100117e","article-title":"Trioxaferroquines as new hybrid antimalarial drugs","volume":"53","author":"Bellot","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2021.113408_bib107","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1128\/AAC.00640-09","article-title":"In\u00a0vitro activities of trioxaquines against Schistosoma mansoni","volume":"53","author":"Boissier","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113408_bib108","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jorganchem.2008.09.033","article-title":"Structure\u2013activity relationships of 4-N-substituted ferroquine analogues: time to re-evaluate the mechanism of action of ferroquine","volume":"694","author":"Biot","year":"2009","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib109","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmech.2015.04.053","article-title":"New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1, 2, 4-trioxane-ferrocene hybrids","volume":"97","author":"Reiter","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejmech.2014.01.043","article-title":"Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells","volume":"75","author":"Reiter","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113408_bib111","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1089\/ars.2009.2541","article-title":"Redox-directed cancer therapeutics: molecular mechanisms and opportunities","volume":"11","author":"Wondrak","year":"2009","journal-title":"Antioxidants Redox Signal."},{"issue":"11","key":"10.1016\/j.ejmech.2021.113408_bib112a","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1039\/c3ra42513d","article-title":"Diversification in the synthesis of antimalarial trioxane and tetraoxane analogs","volume":"4","author":"Yadav","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2021.113408_bib112b","series-title":"Recent Advances in Antimalarial Drug Discovery\u2014Challenges and Opportunities. An Overview of Tropical Diseases","first-page":"39","author":"Sharma","year":"2015"},{"issue":"19","key":"10.1016\/j.ejmech.2021.113408_bib113","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1021\/jm8006905","article-title":"New chimeric antimalarials with 4-aminoquinoline moiety linked to a tetraoxane skeleton","volume":"51","author":"Opsenica","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2021.113408_bib114","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1021\/jm701417a","article-title":"Chemical stability of the peroxide bond enables diversified synthesis of potent tetraoxane antimalarials","volume":"51","author":"Opsenica","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2021.113408_bib115","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2298\/JSC0911155O","article-title":"Antimalarial peroxides","volume":"74","author":"Opsenica","year":"2009","journal-title":"J.\u00a0Serb. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113408_bib116","doi-asserted-by":"crossref","first-page":"1993-2004","DOI":"10.1007\/s00044-016-1644-5","article-title":"Synthesis, antimalarial activity evaluation and docking studies of some novel tetraoxaquines","volume":"25","author":"Kumawat","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113408_bib117","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejmech.2018.02.048","article-title":"Endoperoxide-8-aminoquinoline hybrids as dual-stage antimalarial agents with enhanced metabolic stability","volume":"149","author":"Capela","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113408_bib118","first-page":"1","article-title":"In silico modeling of tetraoxane- 8-aminoquinoline hybrids active against Plasmodium falciparum","volume":"9","author":"Mahmud","year":"2020","journal-title":"Beni-Suef Univ. J. Appl. Sci."},{"key":"10.1016\/j.ejmech.2021.113408_bib119","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1021\/jm5004528","article-title":"Tetraoxaneepyrimidine nitrile hybrids as dual stage antimalarials","volume":"57","author":"Oliveira","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2021.113408_bib120","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1128\/AAC.00264-07","article-title":"Comparative antimalarial activities of six pairs of 1,2,4,5-tetraoxanes (peroxide dimers) and 1,2,4,5,7,8-hexaoxonanes (peroxide trimers)","volume":"51","author":"Dong","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113408_bib121","unstructured":"S. K. Awasthi, A. Kumar, Novel Antimalarial Dispiro-1, 2, 4, 5 Tetraoxanes and One Pot Method of Synthesis Thereof, [Indian Patent no. 201611034971; published in J.No. 15\/2018]."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113408_bib122","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/jm9911027","article-title":"Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism: comparison between mono-and bisquaternary ammonium salts","volume":"43","author":"Calas","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib123","doi-asserted-by":"crossref","DOI":"10.1271\/bbb.80571","article-title":"Synthesis of novel conjugates of tetraoxane endoperoxide with bis (quaternary ammonium salts)","author":"Kumura","year":"2009","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"7","key":"10.1016\/j.ejmech.2021.113408_bib124","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.bmcl.2009.02.028","article-title":"Antitumour and antimalarial activity of artemisinin\u2013acridine hybrids","volume":"19","author":"Jones","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113408_bib125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejps.2014.01.014","article-title":"Synthesis and in\u00a0vitro biological evaluation of aminoacridines and artemisinin\u2013acridine hybrids","volume":"56","author":"Joubert","year":"2014","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"8","key":"10.1016\/j.ejmech.2021.113408_bib126","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.ejmech.2010.04.011","article-title":"Quinolines and structurally related heterocycles as antimalarials","volume":"45","author":"Kaur","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib127","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1016\/j.bmc.2014.12.018","article-title":"Quinoline-based antimalarial hybrid compounds","volume":"23","author":"Vandekerckhove","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1475-2875-10-53","article-title":"Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic Plasmodium falciparum infection","volume":"10","author":"Mombo-Ngoma","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113408_bib129a","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1128\/AAC.05359-11","article-title":"Pharmacokinetics of ferroquine, a novel 4- aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections, Antimicrob","volume":"56","author":"Supan","year":"2012","journal-title":"Agents Chemother"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113408_bib129b","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/cmdc.200700127","article-title":"Ferrocene conjugates of chloroquine and other antimalarials: the development of ferroquine, a new antimalarial","volume":"3","author":"Dive","year":"2008","journal-title":"ChemMedChem: Chemistry Enabling Drug Discovery"},{"key":"10.1016\/j.ejmech.2021.113408_bib130","doi-asserted-by":"crossref","first-page":"111963","DOI":"10.1016\/j.ejmech.2019.111963","article-title":"Design and synthesis of novel ferrocene-quinoline conjugates and evaluation of their electrochemical and antiplasmodium properties","volume":"187","author":"Minic","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2021.113408_bib131","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1128\/AAC.01061-12","article-title":"Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in\u00a0vivo and in\u00a0vitro","volume":"56","author":"S\u00e1enz","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113408_bib132a","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1021\/jm061429p","article-title":"Design and synthesis of potent antimalarial agents based on clotrimazole scaffold: exploring an innovative pharmacophore","volume":"50","author":"Gemma","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113408_bib132b","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1021\/jm801352s","article-title":"Combining 4-aminoquinoline-and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarials","volume":"52","author":"Gemma","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113408_bib133","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1039\/C1MD00188D","article-title":"Synthesis of hybrid 4-anilinoquinoline triazines as potent antimalarial agents, their in silico modeling and bioevaluation as Plasmodium falciparum transketolase and \u03b2-hematin inhibitors","volume":"3","author":"Sharma","year":"2012","journal-title":"Med. Chem. Comm."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113408_bib134","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1747-0285.2011.01115.x","article-title":"Synthesis of 4-aminoquinoline-1, 2, 3-triazole and 4-aminoquinoline-1, 2, 3-triazole-1, 3, 5-triazine Hybrids as Potential Antimalarial Agents","volume":"78","author":"Manohar","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113408_bib135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0163-7258(97)00084-3","article-title":"4-Aminoquinolines\u2014past, present, and future; A chemical perspective","volume":"77","author":"O\u2019Neill","year":"1998","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113408_bib136","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1021\/jm00164a059","article-title":"Synthesis, antiretrovirus effects and phosphorylation kinetics of 3\u2019-isocyano-3\u2019-deoxythymidine and 3\u2019-isocyano-2\u2019, 3\u2019-dideoxyuridine","volume":"33","author":"Hiebl","year":"1990","journal-title":"J.\u00a0Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113408_bib137","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.bmc.2009.01.013","article-title":"Synthesis and in\u00a0vitro antitubercular activity of a series of quinoline derivatives","volume":"17","author":"De Souza","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib138","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejmech.2016.06.033","article-title":"4-Aminoquinoline derivatives: synthesis, in\u00a0vitro and in\u00a0vivo antiplasmodial activity against chloroquine-resistant parasites","volume":"122","author":"Singh","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib139a","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5155\/eurjchem.4.2.121-123.740","article-title":"Synthesis and spectral characterization of some heterocyclic nitrogen compounds","volume":"4","author":"Hassan","year":"2013","journal-title":"Eur. J. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib139b","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5155\/eurjchem.4.2.168-171.762","article-title":"Utility of (2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-acetic acid hydrazide in the synthesis of some heterocyclic nitrogen compounds","volume":"4","author":"Hassan","year":"2013","journal-title":"Eur. J. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib139c","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/10406638.2017.1325747","article-title":"Synthesis, structural, and theoretical studies of quinazoline-2,4-dione derivatives","volume":"39","author":"El-Sheshtawy","year":"2017","journal-title":"Polycycl. Aromat. Comp."},{"key":"10.1016\/j.ejmech.2021.113408_bib139d","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/jhet.3889","article-title":"Synthesis, in vitro biological evaluation and in silico docking studies of new quinazolin-2,4-dione analogues as possible anticarcinoma agents","volume":"57","author":"Abdelmonsef","year":"2020","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib139e","article-title":"Synthesis, characterization, antibacterial activity, and computer-aided design of novel quinazolin-2,4-dione derivatives as potential inhibitors against Vibrio Cholerae","volume":"16","author":"El-Naggar","year":"2020","journal-title":"Evol. Bioinf. Online"},{"key":"10.1016\/j.ejmech.2021.113408_bib139f","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.arabjc.2018.02.017","article-title":"Synthesis of N\u2032-(quinazolin-4-yl)isonicotinohydrazides and their biological screening, docking and ADME studies","volume":"13","author":"Patel","year":"2018","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2021.113408_bib140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fmolb.2020.00105","article-title":"Novel quinazolin-2,4-dione hybrid molecules as possible inhibitors against malaria: synthesis and in silico molecular docking studies","volume":"7","author":"Haredi Abdelmonsef","year":"2020","journal-title":"Front. Mol. Biosci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421002579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421002579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:31:27Z","timestamp":1759329087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421002579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":187,"alternative-id":["S0223523421002579"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113408","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancement of chimeric hybrid drugs to cure malaria infection: An overview with special emphasis on endoperoxide pharmacophores","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113408"}}